FIRST ON FOX: A former Food and Drug Administration (FDA) senior staffer is speaking out about problems at the agency under the Biden administration, including diversity, equity and inclusion (DEI), and failures to combat China flooding the U.S. market with illicit vapes after the FDA’s top tobacco official was removed from his position.

"I think many of us had been anticipating it for quite some time, we knew that change was drastically needed at FDA when it came to tobacco control, because tobacco control had really gotten out of control," David Oliveira, who recently left the FDA after six years, said in response to FDA chief tobacco regulator Brian King being removed from his post earlier this month.

"There were many, many failures in the key core missions for the center that needed dramatic change in new leadership. Many of us, whether it be from public health, consumers, small business owners, industry, including even Senator Dick Durbin, who last year at a hearing said to Brian King, ‘It looks to me like you have fallen down on the job.’ So really it runs the spectrum with the people that are unhappy with what's gone on recently with the FDA in terms of tobacco regulation."

One of the most prominent missteps at the FDA over the past few years, according to Oliveira, was the influx of illicit Chinese vapes into the U.S. market, which he says made him feel like a "canary in a coal mine" as he warned about the potential dangers and little was done.

‘DEEP TIES TO THE...

Read Full Story: https://news.google.com/rss/articles/CBMiugFBVV95cUxPY1FSV2x3Q2dWSG5tTFZ6ZEJr...